Back

REACT-1 round 7 updated report: regional heterogeneity in changes in prevalence of SARS-CoV-2 infection during the second national COVID-19 lockdown in England

Riley, S.; Walters, C. E.; Wang, H.; Eales, O.; Ainslie, K. E. C.; Atchinson, C.; Fronterre, C.; Diggle, P. J.; Ashby, D.; Donnelly, C. A.; Cooke, G.; Barclay, W.; Ward, H.; Darzi, A.; Elliott, P.

2020-12-16 epidemiology
10.1101/2020.12.15.20248244 medRxiv
Show abstract

BackgroundEngland exited a four-week second national lockdown on 2nd December 2020 initiated in response to the COVID-19 pandemic. Prior results showed that prevalence dropped during the first half of lockdown, with greater reductions in higher-prevalence northern regions. MethodsREACT-1 is a series of community surveys of SARS-CoV-2 RT-PCR swab-positivity in England, designed to monitor the spread of the epidemic and thus increase situational awareness. Round 7 of REACT-1 commenced swab-collection on 13th November 2020. A prior interim report included data from 13th to 24th November 2020 for 105,122 participants. Here, we report data for the entire round with swab results obtained up to 3rd December 2020. ResultsBetween 13th November and 3rd December (round 7) there were 1,299 positive swabs out of 168,181 giving a weighted prevalence of 0.94% (95% CI 0.87%, 1.01%) or 94 per 10,000 people infected in the community in England. This compares with a prevalence of 1.30% (1.21%, 1.39%) from 16th October to 2nd November 2020 (round 6), a decline of 28%. Prevalence during the latter half of round 7 was 0.91% (95% CI, 0.81%, 1.03%) compared with 0.96% (0.87%, 1.05%) in the first half. The national R number in round 7 was estimated at 0.96 (0.88, 1.03) with a decline in prevalence observed during the first half of this period no longer apparent during the second half at the end of lockdown. During round 7 there was a marked fall in prevalence in West Midlands, a levelling off in some regions and a rise in London. R numbers at regional level ranged from 0.60 (0.41, 0.80) in West Midlands up to 1.27 (1.04, 1.54) in London, where prevalence was highest in the east and south-east of the city. Nationally, between 13th November and 3rd December, the highest prevalence was in school-aged children especially at ages 13-17 years at 2.04% (1.69%, 2.46%), or approximately 1 in 50. ConclusionBetween the previous round and round 7 (during lockdown), there was a fall in prevalence of SARS-CoV-2 swab-positivity nationally, but it did not fall uniformly over time or by geography. Continued vigilance is required to reduce rates of infection until effective immunity at the population level can be achieved through the vaccination programme.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Journal of Infection
71 papers in training set
Top 0.1%
18.2%
2
Eurosurveillance
80 papers in training set
Top 0.1%
12.2%
3
Wellcome Open Research
57 papers in training set
Top 0.1%
9.9%
4
BMJ Open
554 papers in training set
Top 4%
4.7%
5
BMC Medicine
163 papers in training set
Top 0.8%
4.7%
6
Nature Communications
4913 papers in training set
Top 34%
4.7%
50% of probability mass above
7
The Lancet Infectious Diseases
71 papers in training set
Top 0.6%
3.9%
8
Science
429 papers in training set
Top 9%
3.5%
9
International Journal of Epidemiology
74 papers in training set
Top 0.7%
3.0%
10
The Lancet Regional Health - Europe
32 papers in training set
Top 0.1%
2.8%
11
PLOS ONE
4510 papers in training set
Top 49%
2.0%
12
Emerging Infectious Diseases
103 papers in training set
Top 1%
2.0%
13
Epidemiology and Infection
84 papers in training set
Top 1%
2.0%
14
The Lancet
16 papers in training set
Top 0.2%
2.0%
15
The Lancet Public Health
20 papers in training set
Top 0.2%
1.7%
16
BMJ
49 papers in training set
Top 0.5%
1.7%
17
eClinicalMedicine
55 papers in training set
Top 0.5%
1.7%
18
BMC Infectious Diseases
118 papers in training set
Top 3%
1.7%
19
PLOS Medicine
98 papers in training set
Top 3%
1.6%
20
Journal of Epidemiology and Community Health
32 papers in training set
Top 0.4%
1.3%
21
The Lancet Global Health
24 papers in training set
Top 0.8%
1.2%
22
Thorax
32 papers in training set
Top 0.6%
1.2%
23
New England Journal of Medicine
50 papers in training set
Top 0.7%
0.9%
24
The Lancet Healthy Longevity
11 papers in training set
Top 0.2%
0.8%
25
BMC Public Health
147 papers in training set
Top 6%
0.7%
26
Clinical Infectious Diseases
231 papers in training set
Top 5%
0.7%